Insmed
INSM
#677
Rank
NZ$61.48 B
Marketcap
NZ$285.26
Share price
-1.47%
Change (1 day)
128.50%
Change (1 year)

Earnings for Insmed (INSM)

Earnings in 2025 (TTM): -NZ$2.05 Billion

According to Insmed's latest financial reports the company's current earnings are NZ$0.60 Billion. a decrease over its 2024 earnings that were of -NZ$1.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insmed from 2000 to 2025

Annual earnings

Year Earnings Change
2025 -NZ$2.1 Billion43.91%
2024 -NZ$1.46 Billion23.71%
2023 -NZ$1.18 Billion45.77%
2022 -NZ$0.81 Billion15.83%
2021 -NZ$0.7 Billion50.19%
2020 -NZ$0.47 Billion16.4%
2019 -NZ$0.4 Billion-23.9%
2018 -NZ$0.53 Billion59.35%
2017 -NZ$0.33 Billion8.52%
2016 -NZ$0.31 Billion47.25%
2015 -NZ$0.21 Billion34.53%
2014 -NZ$0.16 Billion58.83%
2013 -NZ$96.39 Million35.14%
2012 -NZ$71.33 Million-31.92%
2011 -NZ$0.11 Billion854.92%
2010 -NZ$10.98 Million-105.22%
2009 NZ$0.21 B-905.06%
2008 -NZ$26.1 Million-27.31%
2007 -NZ$35.9 Million-62.41%
2006 -NZ$95.49 Million98.19%
2005 -NZ$48.18 Million0.03%
2004 -NZ$48.17 Million159.07%
2003 -NZ$18.6 Million-69.31%
2002 -NZ$60.58 Million
2000 -NZ$54.62 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$28.71 B-1,469.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
NZ$17.20 B-920.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.17 B-489.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-NZ$0.45 Billion-78.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-NZ$40.82 Million-98.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
NZ$7.74 M-100.37%๐Ÿ‡บ๐Ÿ‡ธ USA